JPMORGAN CHASE & CO - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$0
-100.0%
51
-97.9%
0.00%
Q3 2020$1,0000.0%2,482
+59.6%
0.00%
Q2 2020$1,000
-99.8%
1,555
-99.7%
0.00%
Q1 2020$502,000
+15.7%
539,339
+153.4%
0.00%
Q4 2019$434,000
-33.1%
212,809
-5.9%
0.00%
Q3 2019$649,000
-63.5%
226,193
-5.9%
0.00%
Q2 2019$1,779,000
-44.9%
240,443
-1.0%
0.00%
-100.0%
Q1 2019$3,227,000
-16.0%
242,767
-1.6%
0.00%0.0%
Q4 2018$3,843,000
-22.7%
246,688
-2.4%
0.00%0.0%
Q3 2018$4,969,000
-44.7%
252,874
-19.3%
0.00%
-50.0%
Q2 2018$8,992,000
-9.6%
313,321
-25.5%
0.00%0.0%
Q1 2018$9,950,000
-20.6%
420,734
-28.0%
0.00%
-33.3%
Q4 2017$12,536,000
-1.2%
584,449
+7.6%
0.00%0.0%
Q3 2017$12,684,000
+90.2%
543,224
+60.4%
0.00%
+50.0%
Q2 2017$6,670,000
-5.1%
338,580
+1.1%
0.00%0.0%
Q1 2017$7,031,000
+29.5%
334,793
+15.9%
0.00%
+100.0%
Q4 2016$5,429,000
-12.8%
288,822
-3.1%
0.00%
-50.0%
Q3 2016$6,224,000
-19.5%
298,075
-1.7%
0.00%0.0%
Q2 2016$7,734,000
+52.3%
303,240
+57.9%
0.00%
+100.0%
Q1 2016$5,079,000
-49.3%
192,015
-17.9%
0.00%
-66.7%
Q4 2015$10,011,000
+42.2%
234,005
-11.9%
0.00%
+50.0%
Q3 2015$7,042,000
-19.7%
265,618
+0.9%
0.00%0.0%
Q2 2015$8,772,000
+56.3%
263,206
+56.0%
0.00%
+100.0%
Q1 2015$5,614,000
+330.2%
168,708
+428.4%
0.00%
Q4 2014$1,305,000
+9.5%
31,930
-9.2%
0.00%
Q3 2014$1,192,000
+8.1%
35,172
+7.5%
0.00%
Q2 2014$1,103,000
-20.7%
32,726
-31.3%
0.00%
Q4 2013$1,391,000
-92.3%
47,643
-90.9%
0.00%
-100.0%
Q3 2013$17,978,000
-5.7%
525,679
-9.0%
0.01%
-16.7%
Q2 2013$19,061,000577,7650.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders